SE425660B - Analogiforfarande for framstellning av 1,4-dihydropyridiner - Google Patents

Analogiforfarande for framstellning av 1,4-dihydropyridiner

Info

Publication number
SE425660B
SE425660B SE7505473A SE7505473A SE425660B SE 425660 B SE425660 B SE 425660B SE 7505473 A SE7505473 A SE 7505473A SE 7505473 A SE7505473 A SE 7505473A SE 425660 B SE425660 B SE 425660B
Authority
SE
Sweden
Prior art keywords
dihydropyridines
preparation
analogy procedure
analogy
procedure
Prior art date
Application number
SE7505473A
Other languages
English (en)
Swedish (sv)
Other versions
SE7505473L (sv
Inventor
E Habicht
H Kuhnis
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE7505473L publication Critical patent/SE7505473L/xx
Publication of SE425660B publication Critical patent/SE425660B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7505473A 1974-06-04 1975-05-13 Analogiforfarande for framstellning av 1,4-dihydropyridiner SE425660B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH763874A CH607848A5 (ja) 1974-06-04 1974-06-04

Publications (2)

Publication Number Publication Date
SE7505473L SE7505473L (sv) 1975-12-05
SE425660B true SE425660B (sv) 1982-10-25

Family

ID=4328235

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7505473A SE425660B (sv) 1974-06-04 1975-05-13 Analogiforfarande for framstellning av 1,4-dihydropyridiner

Country Status (17)

Country Link
US (1) US4017629A (ja)
JP (1) JPS6025423B2 (ja)
AT (1) AT345289B (ja)
BE (1) BE829807A (ja)
CA (1) CA1068706A (ja)
CH (1) CH607848A5 (ja)
DE (1) DE2524277A1 (ja)
DK (1) DK178775A (ja)
ES (1) ES438125A1 (ja)
FR (1) FR2273538A1 (ja)
GB (1) GB1464324A (ja)
HU (1) HU171870B (ja)
IE (1) IE41251B1 (ja)
IL (1) IL47413A (ja)
NL (1) NL7506467A (ja)
SE (1) SE425660B (ja)
ZA (1) ZA753580B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
US4525478A (en) * 1975-07-02 1985-06-25 Fujisawa Pharmaceutical Co., Ltd. Certain 4-aryl-1,4-dihydro-3,5-pyridinedicarboxylates having vasodilating and anti-hypertensive properties
DE2639498A1 (de) * 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
US4491582A (en) * 1983-03-03 1985-01-01 Usv Pharmaceutical Corporation N-(substituted piperazino)-1,4-dihydropyridine-3,5-carboxylic acid
DE3501695A1 (de) * 1985-01-19 1986-07-24 Bayer Ag, 5090 Leverkusen Verwendung von sulfonyl-dihydropyridinen als arzneimittel zur behandlung von asthma
DK224786A (da) * 1985-06-21 1986-12-22 Hoffmann La Roche Dihydropyridinderivater
JPS61293972A (ja) * 1985-06-24 1986-12-24 Nisshin Flour Milling Co Ltd １，４−ジヒドロピリジンスルホン誘導体およびその製法
US4889866A (en) * 1987-06-11 1989-12-26 Syntex (U.S.A.) Inc. Arylsulfonyl dihydropyridine derivatives
US5128474A (en) * 1987-07-10 1992-07-07 Ishihara Sangyo Kaisha Ltd. Mercapto-substituted pyridine compounds, aminocarbonyl-substituted pyridinesulfinic acid compounds and process for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Also Published As

Publication number Publication date
FR2273538B1 (ja) 1978-11-10
HU171870B (hu) 1978-04-28
JPS514179A (en) 1976-01-14
US4017629A (en) 1977-04-12
ATA420075A (de) 1978-01-15
JPS6025423B2 (ja) 1985-06-18
ZA753580B (en) 1976-05-26
NL7506467A (nl) 1975-12-08
AT345289B (de) 1978-09-11
AU8178875A (en) 1976-12-09
CH607848A5 (ja) 1978-11-30
FR2273538A1 (fr) 1976-01-02
DE2524277C2 (ja) 1988-08-04
GB1464324A (en) 1977-02-09
IE41251L (en) 1975-12-04
BE829807A (fr) 1975-12-03
IL47413A0 (en) 1975-08-31
ES438125A1 (es) 1977-05-16
DK178775A (da) 1975-12-05
IL47413A (en) 1978-10-31
IE41251B1 (en) 1979-11-21
DE2524277A1 (de) 1975-12-18
CA1068706A (en) 1979-12-25
SE7505473L (sv) 1975-12-05

Similar Documents

Publication Publication Date Title
NO142401C (no) Analogifremgangsmaate til fremstilling av mavesyresekresjonshemmende 2-pyridylalkyltiobenzimidazoler
SE425489B (sv) Analogiforfarande for framstellning av 1,3,4-trisubstituerade 4-fenyl-piperidiner
SE7513085L (sv) Forfarande for framstellning av etrar
SE425660B (sv) Analogiforfarande for framstellning av 1,4-dihydropyridiner
SE417610B (sv) Analogiforfarande for framstellning av 1-bensazolylalkyl-4-substituerade piperidiner
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
DK153479C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepin-2-on-derivater
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE426827B (sv) Nytt forfarande for framstellning av 7beta-acylamino-7alfa-alkoxicefalosporiner
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
SE424638B (sv) Analogiforfarande for framstellning av 5,7-dihydroxi-tetrahydroisokinolin derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE420999B (sv) Framstellning av 2,4-diamino-5-bensylpyrimidiner
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
SE423233B (sv) Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE420923B (sv) Analogiforfarande for framstellning av derivat av 3?721-nortropyliden-dibenso (b,e)-tiepin
SE423992B (sv) Forfarande for framstellning av 9, 11, 15-trihydroxi-13, 14-dehydroprostaglandiner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7505473-4

Effective date: 19910123

Format of ref document f/p: F